Connor, Clark & Lunn Investment Management (CC&L)’s Cullinan Oncology CGEM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $527K | Sell |
70,044
-7,577
| -10% | -$57.1K | ﹤0.01% | 1238 |
|
2025
Q1 | $588K | Buy |
77,621
+57,348
| +283% | +$434K | ﹤0.01% | 1099 |
|
2024
Q4 | $247K | Buy |
+20,273
| New | +$247K | ﹤0.01% | 1292 |
|
2024
Q2 | – | Sell |
-36,401
| Closed | -$620K | – | 1414 |
|
2024
Q1 | $620K | Buy |
+36,401
| New | +$620K | ﹤0.01% | 1046 |
|